About 9,120 results

ALLMedicine™ Basal Cell Carcinoma Center

Research & Reviews  2,774 results

Basal cell carcinoma: epidemiological impact of clinical versus histopathological diagn...
Journal of the European Academy of Dermatology and Venere... Backman E, Oxelblom M et. al.

Nov 27th, 2022 - Low-risk basal cell carcinomas (BCCs) are to an increasing extent diagnosed by dermatologists through dermoscopic examination only and treated with non-surgical methods. Reports on increasing incidence as well as trends regarding subtypes, anatomi...

An Epidemiological Update on Indoor Tanning and the Risk of Skin Cancers.
Current Oncology (Toronto, Ont.); Dessinioti C, Stratigos AJ

Nov 25th, 2022 - Indoor tanning (sunbeds, solarium) uses artificial ultraviolet radiation (UVR) to stimulate cosmetic tanning of the skin. Indoor tanning has been officially classified as a human carcinogen in 2009 by the International Agency for Research on Cance...

External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator ...
JAMA Dermatology; Gómez-Tomás Á, Bouwes Bavinck JN et. al.

Nov 24th, 2022 - The Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) tool has been developed in the US to facilitate the identification of solid organ transplant recipients (SOTRs) at a higher risk of developing skin cancer. However, it has n...

Basal Cell Carcinoma.
Dermatologic Clinics; Heath MS, Bar A

Nov 22nd, 2022 - Basal cell carcinoma (BCC) is the most common cancer worldwide. Early identification can be made clinically, aided by dermoscopy, in addition to newer imaging technologies such as reflectance confocal microscopy. BCC most commonly demonstrates an ...

Double Primary Malignancies Involving Cutaneous Carcinoma.
The Journal of Craniofacial Surgery; Sung KY, Lee S et. al.

Nov 22nd, 2022 - Multiple primary malignancies (MPMs) refer to the presence of 2 or more histologically distinct malignant tumors in the same individual. The prevalence of MPMs has increased owing to earlier detection of tumors by screening tests and improved trea...

see more →

Guidelines  8 results

Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
Dermatology (Basel, Switzerland); Ramelyte E, Nägeli MC et. al.

Sep 23rd, 2022 - Basal cell carcinoma (BCC) is the most common nonmelanoma skin cancer in Switzerland and worldwide. Most BCCs can be treated in a curative setting. However, patients can develop locally destructive and, rarely, metastatic tumors that require a dif...

Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of t...
Practical Radiation Oncology; Likhacheva A, Awan M et. al.

Dec 14th, 2019 - This guideline reviews the evidence for the use of definitive and postoperative radiation therapy (RT) in patients with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). The American Society for Radiation Oncology convened a...

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdiscipli...
European Journal of Cancer (Oxford, England : 1990); Peris K, Fargnoli MC et. al.

Jul 10th, 2019 - Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization of Research and Treatmen...

Guidelines of care for the management of basal cell carcinoma.
Journal of the American Academy of Dermatology; , et. al.

Jan 15th, 2018 - Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly cura...

Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
The Journal of Laryngology and Otology; Newlands C, Currie R et. al.

Nov 15th, 2016 - This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. This paper provides consensus recommendations on the management of cutaneous basal cell carcinoma and squamous c...

see more →

Drugs  18 results see all →

Clinicaltrials.gov  203 results

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

Oct 14th, 2022 - Background: Persons may be prone to develop cancer for a variety of reasons including: inherited predisposition benign, premalignant, or malignant conditions; environmental exposures shared by family members; previous tumors, immune deficiency, or...

Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment

Oct 14th, 2022 - Superficial basal cell carcinoma (sBCC) can be treated non-invasively, but follow-up is necessary because lesions can reoccur. This study aims to evaluate the additional value of optical coherence tomography (OCT) for the detection of recurrent BC...

Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery

Oct 13th, 2022 - Phase II Clinical Trial Evaluating the Safety and Efficacy of a Tissue Engineered Autologous Skin Substitute Reconstructive Surgery for Basal Cell Carcinoma

Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma

Oct 3rd, 2022 - Locally advanced basal cell carcinoma (BCC) are large BCCs or BCCs located in areas subject to functional and aesthetic risk following surgery or radiotherapy. In these particular situations, surgery and radiotherapy are sometimes not appropriate,...

A Study of Observation and Follow-up in People With Basal Cell Carcinoma

Sep 22nd, 2022 - The purpose of this study is to find out more about how Basal Cell Carcimonas/BCCs grow and to learn more effective ways to monitor and treat these common cancers. This study will not provide any type of treatment for the participants' cancer; it ...

see more →

News  608 results

Dermatologists Predict That Skin Cancer Cases Will Double

Nov 21st, 2022 - The number of skin cancer cases in men and women increases by 10% every year. Experts have drawn a correlation between this increase and the increased intensity of UV radiation in Germany. Skin cancer is already one of the most common forms of can...

Multidisciplinary Discussions Shape Systemic and Surgical Skin Cancer Treatment

Nov 15th, 2022 - Future advances in melanoma and other skin cancers should focus on team-oriented care and increasingly informed treatment sequencing regarding the roles of immunotherapy, targeted therapy, and surgery, according to Carlo Contreras, MD, who emphasi...

New FDA Approval Expands Use of Cemiplimab in NSCLC

Nov 9th, 2022 - A new approval from the US Food and Drug Administration (FDA) expands the use of the immunotherapy PD-1 inhibitor cemiplimab-rwlc (Libtayo) for patients with non–small cell lung cancer (NSCLC). The new indication is for use of cemiplimab in combin...

Oncology Case Challenge: A Construction Worker Who Drinks Daily Has an Eyelid Lesion

Nov 2nd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Dr. Schenk on the Effect of Nivolumab Plus Relatlimab in Basal Cell Carcinoma

Oct 21st, 2022 - Kara M. Schenk, MD, a fellow at Johns Hopkins University, discusses the effect of nivolumab plus relatlimab (Opdualag) in advanced basal cell carcinoma. An ongoing phase 2 trial (NCT03521830) is evaluating the efficacy of nivolumab (Opdivo) monot...

see more →

Patient Education  37 results see all →